HealthEquity, Inc. (HQY): Price and Financial Metrics
HealthEquity, Inc. (HQY)
Today's Latest Price: $41.09 USD
Updated Apr 3 12:00am
Add HQY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 9 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
HQY Stock Summary
- HQY's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,062.02 -- higher than 97.15% of US-listed equities with positive expected earnings growth.
- With a price/earnings ratio of 66.77, Healthequity Inc P/E ratio is greater than that of about 93.27% of stocks in our set with positive earnings.
- With a year-over-year growth in debt of 3,175.37%, Healthequity Inc's debt growth rate surpasses 98.75% of about US stocks.
- Stocks that are quantitatively similar to HQY, based on their financial statements, market capitalization, and price volatility, are FEYE, YY, SMTC, SVMK, and CREE.
- Visit HQY's SEC page to see the company's official filings. To visit the company's web site, go to www.healthequity.com.
HQY Stock Price Chart More Charts
HQY Price/Volume Stats
| Current price | $41.09 | 52-week high | $88.78 |
| Prev. close | $43.89 | 52-week low | $34.40 |
| Day low | $40.55 | Volume | 618,700 |
| Day high | $45.37 | Avg. volume | 992,994 |
| 50-day MA | $63.16 | Dividend yield | N/A |
| 200-day MA | $64.72 | Market Cap | 2.91B |
HealthEquity, Inc. (HQY) Company Bio
HealthEquity Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company was founded in 2002 and is based in Draper, Utah.
HQY Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $41.09 | $104.03 | 137% |
Below please find a table outlining a discounted cash flow forecast for HQY, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Healthequity Inc ranked in the 60th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for Healthequity Inc ended up being:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 70. Its equity weight surpasses that of only 24.01% of free cash flow generating stocks in the Technology sector.
- Its compound free cash flow growth rate, as measured over the past 5.01 years, is 0.6% -- higher than 85.91% of stocks in our DCF forecasting set.
- HQY's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 5%; for context, that number is higher than 45.85% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 132% |
| 1% | 135% |
| 2% | 137% |
| 3% | 139% |
| 4% | 142% |
| 5% | 144% |
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as HQY, try NCR, CCIHY, SLP, DTST, and AMKR.
Loading social stream, please wait...